For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Trellis Bioscience, Inc.

USPTO Granted Patents = 30

% Expired Patents = 26.7

CIPO Patents = 2

EPO Patents = 5

Forward Citations = 169

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Lawrence M Kauvar (30 out of 84 patents)

Angeles Estelles (10 out of 11 patents)

Stefan Ryser (8 out of 8 patents)

4. Orit Foord (7 out of 78 patents)

5. Gizette Sperinde (6 out of 8 patents)

6. Ellen J Collarini (6 out of 9 patents)

7. Minha Park (5 out of 7 patents)

8. Stote Ellsworth (5 out of 5 patents)

9. William Usinger (5 out of 9 patents)

10. Krista Maureen McCutcheon (5 out of 14 patents)

11. Bo Chen (4 out of 6 patents)

12. Reyna J Simon (4 out of 11 patents)

13. Bruce Alan Keyt (4 out of 43 patents)

14. Ying-Ping Jiang (4 out of 9 patents)

15. Lauren Opremcak Bakaletz (4 out of 63 patents)

30 patents: Sort by Forward Citations

1. 12643941 - THERAPEUTIC PROTEIN FORMULATIONS COMPRISING ANTI-DNABII ANTIBODIES AND USES THEREOF (2026-06-02),

2. 12491245 - ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION, AND COMPOSITIONS, COMBINATIONS AND METHODS FOR USE THEREOF (2025-12-09),

3. 12246063 - Immunogen providing an extended protective lifetime against respiratory syncytial virus (RSV) and vaccines thereof (2025-03-11),

4. 12152068 - Binding moieties for biofilm remediation (2024-11-26),

5. 11773143 - Conformational epitopes in respiratory syncytial virus G protein central conserved region (2023-10-03),

6. 11725055 - Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling (2023-08-15),

7. 11248040 - Binding moieties for biofilm remediation (2022-02-15),

8. 11246928 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2022-02-15),

9. 11046764 - Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3 (2021-06-29),

10. 10858431 - Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling (2020-12-08),

11. 10676520 - Antibodies useful in passive influenza immunization (2020-06-09),

12. 10654915 - Antibodies useful in passive influenza immunization (2020-05-19),

13. 10639370 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2020-05-05),

14. 10570193 - Binding moieties for biofilm remediation (2020-02-25),

15. 10233234 - Binding moieties for biofilm remediation (2019-03-19),

Trellis Bioscience, Inc. is a biotechnology company specializing in the discovery and development of therapeutic antibodies. With a focus on innovative approaches to target diseases, Trellis leverages advanced antibody technology platforms to create novel treatments. The company's mission is to improve patients' lives by delivering safe and effective therapies that address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

30 Patents

#102 in Mountain View, CA

#2,672 in California

#11,240 in US

#21,814 in the World

Mountain View, CA, United States of America

Trellis Bioscience, Inc.

Forward Citations = 169

28 inventors:

Lawrence M Kauvar (30 out of 84 patents)

Angeles Estelles (10 out of 11 patents)

Stefan Ryser (8 out of 8 patents)

4. Orit Foord (7 out of 78 patents)

5. Gizette Sperinde (6 out of 8 patents)

Please report any incorrect information to [email protected]

Loading…